Phosphate binders in patients with chronic kidney disease
Open Access
- 1 February 2017
- journal article
- review article
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 40 (1), 9-14
- https://doi.org/10.18773/austprescr.2017.002
Abstract
Hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis, can be ameliorated by oral phosphate binders in conjunction with...Keywords
This publication has 53 references indexed in Scilit:
- Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic reviewBMC Nephrology, 2013
- Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?BMC Nephrology, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Phosphate binders for preventing and treating bone disease in chronic kidney disease patientsEmergencias, 2011
- Economic Evaluation of Sevelamer versus Calcium-Based Phosphate Binders in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Phosphorus Binders and Survival on HemodialysisJournal of the American Society of Nephrology, 2009
- Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney diseaseNephrology Dialysis Transplantation, 2008
- Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burdenNephrology Dialysis Transplantation, 2008
- A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United StatesKidney International, 2004